Multiple Sclerosis Trial, Recruiting NCT06256575 Sponsor: Primus Pharmaceuticals Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

NCT06256575
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with systemic sclerosis (also known as scleroderma)
  • You have at least one "active" open sore on your finger(s) (called a digital ulcer)
  • Your medications for systemic sclerosis have stayed the same for the past 30 days

Who may not be able to join:

  • Your finger sore(s) show signs of infection or tissue death (gangrene)
  • You have an allergy to citrus
  • You have an unstable heart, kidney, or liver condition
  • You currently have any type of active infection in your body
  • You are currently receiving cancer treatment or have a cancer that has not been fully treated
  • You are pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Lukban, Primus Pharmaceuticals

Phone: (480) 483-1410

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Primus Pharmaceuticals
Registry
ClinicalTrials.gov
Start date
2 May 2025
Est. completion
15 July 2027

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Efficacy - Number (%) of healed baseline ulcers

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov